Back to Stocks
Rank #1978GOVX
GeoVax Labs, Inc.
$1.56
12.23% (Daily)
Market Cap
$2.70M
Revenue
$3.35M
Rank by MCap
#1978
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. David Alan Dodd
Headquarters
Smyrna, GA
Employees
17
About GeoVax Labs, Inc.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid...
GeoVax Labs, Inc. Price Chart
Loading chart…